Literature DB >> 15164898

Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndrome.

Alex Sassani1, Larry J Findley, Meir Kryger, Eric Goldlust, Charles George, Terence M Davidson.   

Abstract

STUDY
OBJECTIVES: Drivers suffering from obstructive sleep apnea syndrome (OSAS) have an increased risk for being involved in motor-vehicle collisions. This study estimates, for the first time, the annual OSAS-related collisions, costs, and fatalities in the United States and performs a cost-benefit analysis of treating drivers suffering from OSAS with continuous positive airway pressure (CPAP).
DESIGN: The MEDLINE-PubMed database (1980 to 2003) was searched for information on OSAS. A meta-analysis was performed of studies investigating the relationship between collisions and OSAS. Data from the National Safety Council were used to estimate OSAS-related collisions, costs, and fatalities and their reduction with treatment. Next, the annual cost of treating OSAS with CPAP was calculated. Finally, multiple 1-way sensitivity analyses were performed.
SETTING: N/A. PATIENTS OR PARTICIPANTS: N/A.
INTERVENTIONS: N/A. MEASUREMENTS AND
RESULTS: More than 800,000 drivers were involved in OSAS-related motor-vehicle collisions in the year 2000. These collisions cost 15.9 billion dollars and 1,400 lives in the year 2000. In the United States, treating all drivers suffering from OSAS with CPAP would cost 3.18 billion dollars, save 11.1 billion dollars in collision costs, and save 980 lives annually.
CONCLUSION: Annually, a small but significant portion of motor-vehicle collisions, costs, and deaths are related to OSAS. With CPAP treatment, most of these collisions, costs, and deaths can be prevented. Treatment of OSAS benefits both the patient and the public.

Entities:  

Mesh:

Year:  2004        PMID: 15164898     DOI: 10.1093/sleep/27.3.453

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  102 in total

1.  Sleep disturbances and adverse driving events in a predominantly male cohort of active older drivers.

Authors:  Carlos A Vaz Fragoso; Katy L B Araujo; Peter H Van Ness; Richard A Marottoli
Journal:  J Am Geriatr Soc       Date:  2010-10       Impact factor: 5.562

2.  Reliability of a single objective measure in assessing sleepiness.

Authors:  Bernie Y Sunwoo; Nicholas Jackson; Greg Maislin; Indira Gurubhagavatula; Charles F George; Allan I Pack
Journal:  Sleep       Date:  2012-01-01       Impact factor: 5.849

Review 3.  Factors that influence CPAP adherence: an overview.

Authors:  Gilla K Shapiro; Colin M Shapiro
Journal:  Sleep Breath       Date:  2010-07-27       Impact factor: 2.816

4.  Driving with diabetes in the future: in-vehicle medical monitoring.

Authors:  David Kerr; Tolulope Olateju
Journal:  J Diabetes Sci Technol       Date:  2010-03-01

5.  The 10-year risk of verified motor vehicle crashes in relation to physiologic sleepiness.

Authors:  Christopher Drake; Timothy Roehrs; Naomi Breslau; Eric Johnson; Catherine Jefferson; Holly Scofield; Thomas Roth
Journal:  Sleep       Date:  2010-06       Impact factor: 5.849

Review 6.  [Expert opinions regarding daytime sleepiness in neurological diseases and obstructive sleep apnea syndrome].

Authors:  S Kotterba; M Orth; S Happe; G Mayer
Journal:  Nervenarzt       Date:  2007-08       Impact factor: 1.214

7.  Exploring the mechanisms of the racial disparity in drowsy driving.

Authors:  Michael V Genuardi; Andrew D Althouse; Michael S Sharbaugh; Rachel P Ogilvie; Sanjay R Patel
Journal:  Sleep Health       Date:  2018-04-24

8.  Expenditure on health care in obese women with and without sleep apnea.

Authors:  Katsuhisa Banno; Clare Ramsey; Randy Walld; Meir H Kryger
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

Review 9.  Approach to outpatient management of adult sleep apnea.

Authors:  Neil M Skjodt
Journal:  Can Fam Physician       Date:  2008-10       Impact factor: 3.275

10.  Obstructive sleep apnea and cardiovascular disease in blacks: a call to action from the Association of Black Cardiologists.

Authors:  Oladipupo Olafiranye; Olakunle Akinboboye; Judith E Mitchell; Gbenga Ogedegbe; Girardin Jean-Louis
Journal:  Am Heart J       Date:  2013-02-19       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.